Sort
40,608 grants matching “prostate cancer”
PROSTATE, LUNG, COLORECTAL AND OVARIAN CANCER
$612,973Pacific Health Research Institute · N01 · FY2000 · CN
De-implementation of low value castration for men with prostate cancer
$612,827Ted Albert Skolarus · University Of Michigan At Ann Arbor · R37 · FY2019 · CA
Project 1 - Evolutionary and ecological dynamics of tumor-host interactions
$612,755Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2015 · CA
Strategies for Cancer Vaccine Development: Preclinical Studies
$612,693Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Human Immune Responses to Tumor Antigens for Cancer Vaccine Development
$612,693Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Diet and Genetic Risks for Prostate Cancer
$612,619Fred Hutchinson Cancer Research Center · R01 · FY2003 · CA
Medical Care Burden of Cancer: System and Data Issues
$612,493Mark Christopher Hornbrook · Kaiser Foundation Research Institute · R01 · FY2007 · CA
Genomic Enhancers at 8q24 and Prostate Cancer
$612,476Gerhard A Coetzee · University Of Southern California · R01 · FY2012 · CA
Mechanisms of Prostate Cancer Dormancy in the Bone Marrow Niche
$612,460Russell S Taichman · University Of Michigan At Ann Arbor · U54 · FY2012 · CA
Evaluation of Patients with Low-Risk and Intermediate-Risk Prostate Cancer Scheduled for High-Dose Rate Brachytherapy Using 68Ga-RM2 PET, 68Ga-PSMA-11 PET and Multi Parametric MRI
$612,442Andrei Iagaru · Stanford University · R01 · FY2020 · CA
Breast and Other Carcinoma Clinical Trials Using Immunotherapies
$612,359Margaret Gatti-Mays · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Cancer Immunotherapy Clinical Trials
$612,359Julius Strauss · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Recovery Support for Bladder CA Patients and Caregivers: A Multimodal Approach
$612,325Michael A Diefenbach · Feinstein Institute For Medical Research · R01 · FY2021 · CA
The Impact of FUS-Mediated Brain Cancer Therapy on BBB Transport, Cytokines, and Immunocyte Trafficking
$612,310Kim Butts Pauly · Stanford University · R01 · FY2019 · CA
Survivor QOL/Spouse Satisfaction after Prostate Therapy
$612,250Beth Israel Deaconess Medical Center · R01 · FY2004 · CA
Clinical genomic predictive model of first line androgen receptor inhibitor therapy outcomes in men with mCRPC
$612,180Susan Halabi · Duke University · R01 · FY2024 · CA
Comprehensive Prostate Cancer Characterization by Genomic and Transcriptomic Prof
$612,154Mark A. Rubin · Weill Medical Coll Of Cornell Univ · R01 · FY2011 · CA
The Effect of Diet and Nutrients on the Progression and Treatment of Prostate Can
$612,120George Thomas · University Of Cincinnati · U01 · FY2012 · CA
Genomic Enhancers at 8q24 and Prostate Cancer
$612,060Gerhard A Coetzee · University Of Southern California · R01 · FY2011 · CA
Advanced PET-CT Directed Post-Prostatectomy Radiotherapy to Enhance Prostate Cancer Outcomes
$611,964Ashesh Jani · Emory University · R01 · FY2022 · CA
Developmental Funds
$611,624Herbert Kim Lyerly · Duke University · P30 · FY2014 · CA
Appraisal and Diagnostic Delay in Colon Cancer
$611,611Maria D. Thomson · Virginia Commonwealth University · R01 · FY2012 · CA
Microfluidic isolation and molecular analysis of circulating tumor cells for the study of neuroendocrine transdifferentiation in prostate cancer
$611,570Mehmet Toner · Massachusetts General Hospital · U01 · FY2025 · CA
Project 1: Design Rules for Spherical Nucleic Acids that Target Cancer
$611,563Milan Mrksich · Northwestern University At Chicago · U54 · FY2016 · CA
Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
$611,560Washington University · N01 · FY2009 · CA